Cardiovascular effects of novel imidazoline congeners

Bollettino Chimico Farmaceutico

Volumn 137, Issue 7, 1998, Pages 229-232

  Shukla, S ^a   Bhalla, M ^a   Misra, U ^a   Mukerjee, D ^a   Saxsena, A K ^a   Sinha, J N ^a   Shanker, K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cardiovascular activity; Carotid occlusion; Hypotension; Imidazoline; Nor epinephrine

Indexed keywords

IMIDAZOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR EFFECT; CAROTID ARTERY OBSTRUCTION; CYCLIZATION; DOG; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; HEART RATE; MALE; NONHUMAN;

ANIMALS; CARDIOVASCULAR AGENTS; DOGS; FEMALE; HEMODYNAMIC PROCESSES; IMIDAZOLES; MALE;

EID: 0031712267     PISSN: 00066648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Chern J.W., Tao P.L., Yen M.H., Lu G.Y., Shian C.Y., Lai Y.J., J. Med.Chem., 36, 2196 (1993).
2. Robinson K.A., Robinson C.P., Castaner J., Drug of the future. 21(11), 1129, (1996).
3. Mealy N., Castaner J., Drug of the future. 21(2), 139, (1996).
4. Iradyan M.A., Khim.-Farm Zh, 11(4), 22, (1997).
5. Dubey M., Verma V.K., Shanker K., Sinha J.N., Bhargava K.P., Kishore K., Pharmazie. 33(5), 268, (1978).
6. Albrecht R.F., Int. Anesthesiol. Clin., 16, 299 (1978).
7. Smith C.C., J. Pharmacol. Exp. Ther., 120, 408 (1950).